Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer.
第一作者:
Tetsuhiro,Yoshinami
第一单位:
Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3, Nakamichi, Higashinari-ku, Osaka, Japan. yosinami-te@mc.pref.osaka.jp.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);疲劳(Fatigue);女(雌)性(Female);人类(Humans);中年人(Middle Aged);中性粒细胞减少(Neutropenia);紫杉酚(Paclitaxel);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1007/s12282-016-0686-3
PMID
27010394
发布时间
2018-01-10
- 浏览32

Breast cancer (Tokyo, Japan)
147-151页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文